Gupta Aditya K, Quinlan Emma M, Venkataraman Maanasa, Bamimore Mary A
Mediprobe Research Inc., London, ON, Canada.
Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
J Cosmet Dermatol. 2022 Jan;21(1):108-117. doi: 10.1111/jocd.14525. Epub 2021 Oct 29.
Microneedling is a relatively novel therapeutic modality introduced in the 1990s where small, fine needles are used to create micro punctures in the skin. It is a minimally invasive procedure used for various dermatological conditions, including androgenetic alopecia (AGA).
We comprehensively summarize the literature regarding microneedling in dermatology. We performed linear multivariable regressions to synthesize evidence from the clinical trials that investigated the efficacy of microneedling for AGA. Studies eligible for quantitative analyses were assessed for evidence quality.
The exact mechanism of microneedling action is yet to be determined, with theories that include the wound-healing cascade. Microneedling monotherapy significantly increased total hair count more than topical minoxidil 5% (β = 12.29; p < 0.001). The combination treatment of microneedling with topical 5% minoxidil increased total hair count significantly compared to monotherapy with microneedling (β = 7.63, p < 0.05). Increasing the overall treatment duration of microneedling and reducing the frequency of microneedling sessions may positively influence an increase in total hair count.
There are limited studies that investigate microneedling as a monotherapy for hair loss since majority of the trials combine it with other therapies such as topical minoxidil or platelet-rich plasma. While preliminary results look promising, further investigation of microneedling as a monotherapy in larger, randomized controlled trials will help determine its safety and efficacy, and place in treating AGA.
微针疗法是20世纪90年代引入的一种相对新颖的治疗方式,使用细小的针在皮肤上制造微小创口。它是一种用于多种皮肤病的微创手术,包括雄激素性脱发(AGA)。
我们全面总结了关于微针疗法在皮肤科应用的文献。我们进行了线性多变量回归分析,以综合来自研究微针疗法对AGA疗效的临床试验的证据。对符合定量分析条件的研究进行证据质量评估。
微针作用的确切机制尚待确定,相关理论包括伤口愈合级联反应。微针单一疗法显著增加的总毛发数量超过5%的外用米诺地尔(β = 12.29;p < 0.001)。与微针单一疗法相比,微针与外用5%米诺地尔联合治疗显著增加了总毛发数量(β = 7.63,p < 0.05)。增加微针疗法的总体治疗时长并减少微针治疗疗程的频率可能对总毛发数量的增加产生积极影响。
由于大多数试验将微针疗法与其他疗法(如外用米诺地尔或富含血小板血浆)联合使用,研究微针疗法作为脱发单一疗法的研究有限。虽然初步结果看起来很有前景,但在更大规模的随机对照试验中进一步研究微针疗法作为单一疗法将有助于确定其安全性和疗效,以及在治疗AGA中的地位。